May 3, 2022 — Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., today announced the release of the SunSCAN 3D cylindrical water scanning system for linear accelerator (linac) commissioning, beam scanning and annual Quality Assurance (QA) in Radiation Therapy. The SunSCAN 3D water scanning system is the latest addition to Sun Nuclear’s comprehensive solutions portfolio for independent, integrated Quality Management of Radiation Therapy and Diagnostic Imaging.
Building on the capabilities of the groundbreaking Sun Nuclear 3D SCANNER water tank, released in 2011 and with more than 1,000 units in use, the SunSCAN 3D water scanning system introduces faster, easier workflows and hyper-accurate dosimetry. This system maintains the cylindrical tank design, which eliminates the need for Medical Physics teams to shift the tank and keeps detector orientation consistent. Users can be ready to scan in just 15 minutes, by simply rolling the tank in place, starting the filling process, and running the faster, more accurate AutoSetup routine.
To meet the increased prevalence of stereotactic treatment deliveries, the SunSCAN 3D system offers enhanced SRS accuracy of 0.1 mm throughout the 3D volume, and enhanced electrometer signal-to-noise ratios for these highly precise treatment deliveries.
New, intuitive SunDOSE software completes the SunSCAN 3D system for streamlined commissioning and annual QA workflows, with enhanced multi-tasking across the software program, easily optimizable scanning queues, and more.
“Commissioning and beam scanning are critical foundations in a strong Radiation Therapy program. Based on a decade of experience with our legacy water tank, we’ve made the new SunSCAN 3D water scanning system easier and faster for every user in the Medical Physics department,” noted Eric Schloesser, Sun Nuclear President. “Plus, as stereotactic treatment deliveries continue to increase globally, it was fundamentally important that the new water scanning system be hyper accurate to meet the demanding needs of SRS and SBRT treatments.”
The SunSCAN 3D system will be on display, and available for demonstrations, in the Sun Nuclear booth during ESTRO 2022, May 6-10, in Copenhagen, Denmark. ESTRO 2022 is the annual meeting of the European Society for Radiotherapy and Oncology, with a membership base of 7,600 Radiation Oncology professionals globally.
On May 17th, Sun Nuclear will host an online Spring 2022 Release Event, with insights on product updates, including the SunSCAN 3D system, the SunCHECK Platform, and a comprehensive portfolio of independent, integrated Quality Management solutions for Radiation Therapy and Diagnostic Imaging. Learn more about the event and register to join at: sunnuclear.com/spring22.
The SunSCAN 3D system is not available for sale in all markets. CE mark pending.
For more information: www.sunnuclear.com
March 29, 2023 
![A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients](/sites/default/files/styles/feed_medium/public/Screen%20Shot%202023-03-16%20at%201.46.39%20PM.png?itok=a2-uUeQz)
